Chatham Lodging Trust — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Chatham Lodging Trust filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $295.08M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $317.21M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $311.11M | Feb 27, 2026 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $317.21M | Feb 26, 2025 |
| FY2024 | Dec 31, 2023 | $311.11M | Feb 26, 2025 |
| FY2024 | Dec 31, 2022 | $294.85M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $203.98M | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $29.57M | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | $34.97M | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | $20.17M | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | $60.21M | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $74.70M | Feb 24, 2021 |
| FY2020 | Sep 30, 2019 | $90.08M | Feb 24, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.05M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.17M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.64M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $9.81M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | ($18.41M) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | ($3.36M) | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | ($18.06M) | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | ($26.83M) | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | ($27.78M) | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | ($2.35M) | Feb 24, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.88M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $33.22M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $28.61M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $36.45M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | ($17.21M) | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | $4.90M | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | ($10.25M) | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | ($18.62M) | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | ($17.69M) | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $7.46M | Feb 24, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.59M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $18.39M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $17.52M | Feb 27, 2026 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.08M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $73.83M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $76.44M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $71.54M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $28.78M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($19.96M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $86.23M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $86.22M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $86.69M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $87.67M | Feb 25, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.25B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.34B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.34B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.41B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.37B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.44B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $1.44B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.39B | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $1.30B | Feb 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $392.33M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $462.68M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $539.55M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $525.74M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $596.51M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $677.80M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $663.55M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $632.29M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $582.44M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $621.36M | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $740.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $758.22M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $776.06M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $794.89M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $797.50M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $677.75M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $762.38M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $797.47M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $803.16M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $676.74M | Feb 27, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($299.53M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($289.13M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($271.65M) | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | ($252.67M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | ($251.10M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($228.72M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($142.37M) | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | ($99.29M) | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | ($69.02M) | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | ($45.66M) | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $20.20M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $68.13M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $26.27M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $19.19M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $21.12M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $6.62M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $7.19M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $9.33M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $12.12M | Feb 27, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $338.91M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $406.85M | Feb 27, 2026 |
| FY2023 | Dec 31, 2023 | $486.11M | Feb 27, 2024 |
| FY2022 | Dec 31, 2022 | $470.26M | Feb 23, 2023 |
| FY2021 | Dec 31, 2021 | $544.93M | Feb 25, 2022 |
| FY2021 | Dec 31, 2020 | $609.74M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $586.86M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $585.06M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $540.45M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | $585.06M | Feb 27, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 24, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 27, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 24, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 47.71M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 48.91M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 48.86M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 48.81M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 48.77M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 46.97M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 46.93M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 46.54M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | 45.38M | Feb 25, 2019 |
| FY2017 | Dec 31, 2016 | 38.37M | Feb 27, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.61M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $14.38M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $14.21M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $147.0K | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $282.0K | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $16.24M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $62.66M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $61.59M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $52.62M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $52.97M | Feb 25, 2019 |